# |
Query |
Results |
S40 |
S27 AND S39 |
111 |
S39 |
S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 |
1,105,194 |
S38 |
TX allocat* random* |
5,945 |
S37 |
(MH "Quantitative Studies") |
15,237 |
S36 |
(MH "Placebos") |
9,967 |
S35 |
TX placebo* |
43,010 |
S34 |
TX random* allocat* |
5,945 |
S33 |
(MH "Random Assignment") |
42,264 |
S32 |
TX randomi* control* trial* |
117,316 |
S31 |
TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) |
870,796 |
S30 |
TX clinic* n1 trial* |
197,987 |
S29 |
PT Clinical trial |
79,975 |
S28 |
(MH "Clinical Trials+") |
208,852 |
S27 |
S18 AND S26 |
364 |
S26 |
S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 |
30,510 |
S25 |
TX Estradiol or TX oestrogen or TX estrogen or TX oestradiol |
17,624 |
S24 |
TX desogestral or TX desogestrel or TX Gestagen |
76 |
S23 |
TX Norgestrel or TX Norethindrone TX Norethisterone |
19 |
S22 |
TX progestagen* or TX progestin* or TX progestogen* |
1,722 |
S21 |
TX Pretreatment |
7,437 |
S20 |
TX oral contraceptive* |
6,329 |
S19 |
(MH "Contraceptives, Oral Combined") OR (MM "Contraceptives, Oral") |
3,014 |
S18 |
S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 |
7,460 |
S17 |
TX (ovari* N2 induction) |
15 |
S16 |
TX COH |
119 |
S15 |
TX ovarian hyperstimulation |
403 |
S14 |
TX superovulat* |
24 |
S13 |
TX ovulation induc* |
660 |
S12 |
TX intrauterine insemination |
185 |
S11 |
TX IUI |
117 |
S10 |
TX assisted reproduct* |
1,678 |
S9 |
(MM "Reproduction Techniques+") |
4,518 |
S8 |
TX intracytoplasmic sperm injection* |
308 |
S7 |
TX embryo* N3 transfer* |
985 |
S6 |
TX ovar* N3 hyperstimulat* |
406 |
S5 |
TX ovari* N3 stimulat* |
335 |
S4 |
TX IVF or TX ICSI |
1,757 |
S3 |
(MM "Fertilization in Vitro") |
1,659 |
S2 |
TX vitro fertilization |
3,491 |
S1 |
TX vitro fertilisation |
3,491 |